Articles by author - Michal Kolárik

Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro.

Kolarik M, Indra R, Adam V, Heger Z, Kopeckova K, Arlt V, Stiborova M.

Journal Article 2019; 39(7): 515-524 PubMed PMID: 30860683  Keywords:  Anilides:pharmacology, Animals, Cytochrome P-450 Enzyme Inhibitors:pharmacology, Ellipticines:pharmacokinetics, Humans, Microsomes, Liver:drug effects, Oxidation-Reduction:drug effects, Peroxidases:antagonists & inhibitors, Phenylurea Compounds:pharmacolo.    Citation

OBJECTIVES: Vandetanib¸ lenvatinib, and cabozantinib are tyrosine kinase inhibitors (TKIs) targeting VEGFR subtypes 1 and 2, EGFR and the.....

Read abstract  Full text PDF

Hybrid Artificial Intelligence Solution Combining Convolutional Neural Network and Analytical Approach Showed Higher Accuracy in A-lines Detection on Lung Ultrasound in Thoracic Surgery Patients Compared with Radiology Resident.

Števík M, Malík M, Dzian A, Vetešková Š, Trabalková Z, Hliboký M, Kolárik M, Magyar J, Bundzel M, Szabóová M, Babič F, Grendár M, Zeleňák K, Máčajová V, Drobná Sániová B.

Journal Article 2024; 45(3): 229-237 PubMed PMID: 39146568 Citation

OBJECTIVES: Lung ultrasound reduces the number of chest X-rays after thoracic surgery and thus the radiation. COVID-19 pandemic has accele.....

Read abstract  Full text PDF